Liraglutide exemplifies this approach through specific molecular modifications
Impact on Drug Manufacturers: The CAA 2026 rebate pass-through mandate and Express Scripts announced transition to a rebate-free model by 2028 are already reshaping pharmaceutical pricing strategies
The Company also plans to further enhance patient convenience and adoption with the introduction of a pen-device version in April priced at MRP of INR 4,000, INR 4,200 and INR 4,500 per month for the strengths 2mg/1.5ml, 4mg/3ml and 8mg/3ml respectively
Read More Key Benefits DUAL-ACTION TECHNOLOGY- Revolutionary technology that combines oil-based and water-based ingredients to work together for a radiant, visibly brighter complexion
Early intervention prevents minor problems from becoming major complications requiring extensive treatment
The goal should be sustainable, steady progress under medical supervision